Lv61
1730 积分 2021-04-05 加入
Targeting Oncogenic Transcriptional Factor c-Myc by Oligonucleotide PROTAC for the Treatment of Hepatocellular Carcinoma
22天前
已完结
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications
29天前
已完结
[EML4-ALK fusion gene in patients with lung carcinoma: biology, diagnostics and targeted therapy]
29天前
已关闭
Going beneath the tip of the iceberg. Identifying and understanding EML4-ALK variants and TP53 mutations to optimize treatment of ALK fusion positive (ALK+) NSCLC
29天前
已完结
EML4-ALK fusion gene in non-small cell lung cancer
29天前
已关闭
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC
30天前
已完结
Sialyltransferase ST3GAL4 confers osimertinib resistance and offers strategies to overcome resistance in non-small cell lung cancer
30天前
已完结
NUAK1-Mediated Phosphorylation of NADK Mitigates ROS Accumulation to Promote Osimertinib Resistance in Non-Small Cell Lung Carcinoma
30天前
已完结
Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory study
1个月前
已完结
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
1个月前
已完结
皖公网安备34019202002308
